Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

GelTex reports preliminary phase IIc results for RenaGel

April 10, 1997

Urologix's PMA for T3 System accepted for review

April 7, 1997

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Anaritide and acute renal failure

April 1, 1997

Cheung Laboratories initiates preclinicals of BPH treatment system

March 27, 1997

Pharmacia & Upjohn seeks FDA approval for incontinence drug

March 27, 1997

Alpha-adrenoceptor blockers from SKB

March 27, 1997

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...